Works matching IS 17597706 AND DT 2023 AND VI 14 AND IP 25

Results: 15

Intraoperative control of air leak using a sutureless free pericardial fat pad covering method in lung cancer resection.

Published in:

Thoracic Cancer, 2023, v. 14, n. 25, p. 2627, doi. 10.1111/1759-7714.15065

By:

Koike, Sachie;
Kobayashi, Nobutaka;
Miyazawa, Masahisa

Publication type:

Article

Efficacy and safety of immune checkpoint inhibitor rechallenge in non‐small cell lung cancer: A systematic review and meta‐analysis.

Published in:

Thoracic Cancer, 2023, v. 14, n. 25, p. 2536, doi. 10.1111/1759-7714.15063

By:

Feng, Yu;
Tao, Yunxia;
Chen, Haizhu;
Zhou, Yu;
Tang, Le;
Liu, Chenwei;
Hu, Xingsheng;
Shi, Yuankai

Publication type:

Article

Survival analysis of surgical versus nonsurgical treatment in stage I to III small cell lung cancer in the last 20 years: A systematic review and meta‐analysis.

Published in:

Thoracic Cancer, 2023, v. 14, n. 25, p. 2525, doi. 10.1111/1759-7714.15062

By:

Liang, Zhijian;
Li, Xiaoqi;
Li, Xiao

Publication type:

Article

Correction to "Neoadjuvant ceritinib treatment in ALK‐rearranged locally advanced adenosquamous carcinoma: A case report".

Published in:: Thoracic Cancer, 2023, v. 14, n. 25, p. 2632, doi. 10.1111/1759-7714.15048
Publication type:: Article

Correction to "Clinical benefit of platinum doublet combination therapy in older adults with advanced non‐small cell lung cancer: A prospective multicenter study by the National Hospital Organization in Japan".

Published in:: Thoracic Cancer, 2023, v. 14, n. 25, p. 2631, doi. 10.1111/1759-7714.15047
Publication type:: Article

Refractory response to entrectinib for ROS‐1 rearranged NSCLC with concurrent de novo TP53 mutation showing good response to CNS lesion, but poor duration of response: A case report.

Published in:

Thoracic Cancer, 2023, v. 14, n. 25, p. 2622, doi. 10.1111/1759-7714.15044

By:

Ito, Kentaro;
Nishio, Miho;
Fujiwara, Kentaro;
Nishii, Yoichi;
Ushiro, Kengo;
Yasui, Hiroki;
Hataji, Osamu

Publication type:

Article

Tumor budding and tumor‐infiltrating lymphocytes can predict prognosis in pT1b esophageal squamous cell carcinoma.

Published in:

Thoracic Cancer, 2023, v. 14, n. 25, p. 2608, doi. 10.1111/1759-7714.15043

By:

Li, Zhuo;
Liu, Linxiu;
Wang, Bingzhi;
Ying, Jianming;
He, Jie;
Xue, Liyan

Publication type:

Article

Predictors of lung injury during durvalumab maintenance therapy following concurrent chemoradiotherapy in unresectable locally advanced non‐small cell lung carcinoma.

Published in:

Thoracic Cancer, 2023, v. 14, n. 25, p. 2601, doi. 10.1111/1759-7714.15042

By:

Hirama, Nobuyuki;
Yamamoto, Masaki;
Nagaoka, Satoshi;
Segawa, Wataru;
Sugimoto, Chihiro;
Nagayama, Hirokazu;
Hiro, Shuntaro;
Kajita, Yukihito;
Maeda, Chihiro;
Kubo, Sousuke;
Seki, Kenichi;
Nagahara, Yoshinori;
Teranishi, Shuhei;
Tashiro, Ken;
Hara, Yu;
Kobayashi, Nobuaki;
Watanabe, Shigenobu;
Kudo, Makoto;
Kaneko, Takeshi

Publication type:

Article

Issue Information.

Published in:: Thoracic Cancer, 2023, v. 14, n. 25, p. 2523, doi. 10.1111/1759-7714.14511
Publication type:: Article

A case of CD74‐ROS1‐positive lung adenocarcinoma diagnosed by next‐generation sequencing achieved long‐term survival with pemetrexed regimens.

Published in:

Thoracic Cancer, 2023, v. 14, n. 25, p. 2618, doi. 10.1111/1759-7714.15041

By:

Tanaka, Satoshi;
Yoshimura, Nobuaki;
Asakawa, Ryo;
Tobita, Satoshi;
Yaga, Moto;
Ueno, Kiyonobu

Publication type:

Article

SETD1A‐mediated H3K4me3 methylation upregulates lncRNA HOXC‐AS3 and the binding of HOXC‐AS3 to EP300 and increases EP300 stability to suppress the ferroptosis of NSCLC cells.

Published in:

Thoracic Cancer, 2023, v. 14, n. 25, p. 2579, doi. 10.1111/1759-7714.15037

By:

Shi, Zhenliang;
Zhang, Hao;
Shen, Yimeng;
Zhang, Sipei;
Zhang, Xun;
Xu, Yijun;
Sun, Daqiang

Publication type:

Article

Intraoperative lung ultrasound improves subcentimetric pulmonary nodule localization during VATS: Results of a retrospective analysis.

Published in:

Thoracic Cancer, 2023, v. 14, n. 25, p. 2558, doi. 10.1111/1759-7714.15027

By:

Gambardella, Claudio;
Messina, Gaetana;
Pica, Davide Gerardo;
Bove, Mary;
Capasso, Francesca;
Mirra, Rosa;
Natale, Giovanni;
D'Alba, Francesco Panini;
Caputo, Alessia;
Leonardi, Beatrice;
Puca, Maria Antonietta;
Giorgiano, Noemi Maria;
Pirozzi, Mario;
Farese, Stefano;
Zotta, Alessia;
Miele, Francesco;
Vicidomini, Giovanni;
Docimo, Ludovico;
Fiorelli, Alfonso;
Ciardiello, Fortunato

Publication type:

Article

Comprehensive assessment of pretreatment sarcopenia impacts on patients with EGFR‐mutated NSCLC treated with afatinib.

Published in:

Thoracic Cancer, 2023, v. 14, n. 25, p. 2548, doi. 10.1111/1759-7714.15017

By:

Wu, Chen‐Te;
Hsu, Ping‐Chih;
Chang, John Wen‐Cheng;
Chang, Ching‐Fu;
Huang, Chen‐Yang;
Yang, Cheng‐Ta;
Kuo, Chih‐Hsi Scott;
Fang, Yueh‐Fu;
Wu, Chiao‐En

Publication type:

Article

Personalized cancer avatars for patients with thymic malignancies: A pilot study with circulating tumor cell‐derived organoids.

Published in:

Thoracic Cancer, 2023, v. 14, n. 25, p. 2591, doi. 10.1111/1759-7714.15039

By:

Wu, Yuan‐Hung;
Chao, Heng‐sheng;
Chiang, Chi‐Lu;
Luo, Yung‐Hung;
Chiu, Chao‐Hua;
Yen, Sang‐Hue;
Liu, Chun‐Yu;
Chiou, Jeng‐Fong;
Burnouf, Thierry;
Chen, Yin‐Ju;
Wang, Peng‐Yuan;
Chao, Tsu‐Yi;
Hsu, Shih‐Ming;
Lu, Long‐Sheng

Publication type:

Article

Using the neutrophil‐to‐lymphocyte ratio to predict the outcome of individuals with nonsquamous non‐small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed.

Published in:

Thoracic Cancer, 2023, v. 14, n. 25, p. 2567, doi. 10.1111/1759-7714.15036

By:

Imai, Hisao;
Wasamoto, Satoshi;
Tsuda, Takeshi;
Nagai, Yoshiaki;
Kishikawa, Takayuki;
Masubuchi, Ken;
Osaki, Takashi;
Miura, Yosuke;
Umeda, Yukihiro;
Ono, Akihiro;
Minemura, Hiroyuki;
Yamada, Yutaka;
Nakagawa, Junichi;
Kozu, Yuki;
Taniguchi, Hirokazu;
Ohta, Hiromitsu;
Kasai, Takashi;
Kaira, Kyoichi;
Kagamu, Hiroshi

Publication type:

Article